On the recordFebruary 26, 2018
Mandating the coverage of abuse deterrent opioids is a flawed approach and the FDA acknowledges that these products are not abuse proof.
Source
congress.govMandating the coverage of abuse deterrent opioids is a flawed approach and the FDA acknowledges that these products are not abuse proof.
Gillibrand criticizes mandatory coverage of abuse deterrent opioids.
Share
More from Kirsten Gillibrand
This exposure is especially harmful to children, who are at disproportionate risk for adverse effects. I'm proud to deliver this funding from the Housing Appropriations bill that I negotiated to help clear hazardous lead paint from homes…
Republicans’ roster of corruption and candidates who have been a rubber stamp to Trump is very much affecting their campaigns.
Empowering young people to vote is critical to the future of our democracy. We must ensure that they can make their voices heard loud and clear at the ballot box.